These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 20465719)

  • 1. Paclitaxel-eluting stents for chronically occluded saphenous vein grafts (EOS) study.
    Jim MH; Ho HH; Ko RL; Siu CW; Yiu KH; Lau CP; Chow WH
    J Interv Cardiol; 2010 Feb; 23(1):40-5. PubMed ID: 20465719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of sirolimus-eluting stents with paclitaxel-eluting stents in saphenous vein graft intervention (from a multicenter Southern California Registry).
    Lee MS; Hu PP; Aragon J; Shah AP; Oyama J; Dhoot J; Iqbal Z; Jones N; Penny W; Tobis J; Mahmud E; French W
    Am J Cardiol; 2010 Aug; 106(3):337-41. PubMed ID: 20643242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term clinical outcomes of real-world experience using sirolimus-eluting stents in saphenous vein graft disease.
    Ramana RK; Ronan A; Cohoon K; Homan D; Sutherland J; Steen L; Liu J; Loeb H; Lewis BE
    Catheter Cardiovasc Interv; 2008 Jun; 71(7):886-93. PubMed ID: 18412238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Could Paclitaxel-eluting stents be superior to sirolimus-eluting stents for the treatment of saphenous vein graft lesions?
    Brilakis ES; Banerjee S
    Am J Cardiol; 2010 Nov; 106(9):1367-8. PubMed ID: 21029842
    [No Abstract]   [Full Text] [Related]  

  • 5. Percutaneous intervention of acutely occluded saphenous vein grafts: contemporary techniques and outcomes.
    Abdel-Karim AR; Banerjee S; Brilakis ES
    J Invasive Cardiol; 2010 Jun; 22(6):253-7. PubMed ID: 20516502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic total occlusion treatment in post-CABG patients: saphenous vein graft versus native vessel recanalization-long-term follow-up in the drug-eluting stent era.
    Meliga E; García-García HM; Kukreja N; Daemen J; Tanimoto S; Ramcharitar S; van Mieghem CA; Sianos G; van der Ent M; van der Giessen WJ; de Feyter P; van Domburg R; Serruys PW
    Catheter Cardiovasc Interv; 2007 Jul; 70(1):21-5. PubMed ID: 17584913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcomes of drug-eluting stents versus bare-metal stents in saphenous vein graft disease: results from the Prairie "Real World" Stent Registry.
    Goswami NJ; Gaffigan M; Berrio G; Plessa AL; Pfeiffer AM; Markwell SJ; Mishkel GJ
    Catheter Cardiovasc Interv; 2010 Jan; 75(1):93-100. PubMed ID: 19787803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short- and long-term outcomes after stent-assisted percutaneous treatment of saphenous vein grafts in the drug-eluting stent era.
    Pucelikova T; Mehran R; Kirtane AJ; Kim YH; Fahy M; Weisz G; Lansky AJ; Moussa I; Gray WA; Collins MB; Kodali SK; Stone GW; Moses JW; Leon MB; Dangas G
    Am J Cardiol; 2008 Jan; 101(1):63-8. PubMed ID: 18157967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-eluting stent in saphenous vein graft lesions.
    Kornowski R
    Catheter Cardiovasc Interv; 2008 Jun; 71(7):894-5. PubMed ID: 18498140
    [No Abstract]   [Full Text] [Related]  

  • 10. Sirolimus-eluting stents versus paclitaxel-eluting stents in patients with chronic renal insufficiency.
    Syed AI; Ben-Dor I; Collins SD; Gonzalez MA; Gaglia MA; Torguson R; Satler LF; Suddath WO; Pichard AD; Lindsay J; Waksman R
    J Interv Cardiol; 2010 Feb; 23(1):33-9. PubMed ID: 20465718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five-year clinical outcome of titanium-nitride-oxide-coated bioactive stent implantation in a real-world population: a comparison with paclitaxel-eluting stents: the PORI registry.
    Karjalainen PP; Ylitalo A; Airaksinen JK; Nammas W
    J Interv Cardiol; 2011 Feb; 24(1):1-8. PubMed ID: 21039884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and angiographic outcomes after percutaneous recanalization of chronic total saphenous vein graft occlusion using modern techniques.
    Al-Lamee R; Ielasi A; Latib A; Godino C; Ferraro M; Arioli F; Mussardo M; Piraino D; Figini F; Carlino M; Montorfano M; Chieffo A; Colombo A
    Am J Cardiol; 2010 Dec; 106(12):1721-7. PubMed ID: 21126616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous intervention on the saphenous vein bypass grafts--long-term outcomes.
    Bansal D; Muppidi R; Singla S; Sukhija R; Zarich S; Mehta JL; Sachdeva R
    Catheter Cardiovasc Interv; 2008 Jan; 71(1):58-61. PubMed ID: 18098183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poor long-term patient and graft survival after primary percutaneous coronary intervention for acute myocardial infarction due to saphenous vein graft occlusion.
    Brodie BR; VerSteeg DS; Brodie MM; Hansen C; Richter SJ; Stuckey TD; Gupta N; Pulsipher M; Downey W
    Catheter Cardiovasc Interv; 2005 Aug; 65(4):504-9. PubMed ID: 15988742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early experience with a new approach for percutaneous intervention of totally occluded saphenous vein graft: is the flow the best thrombolytic?
    Fiorina C; Meliga E; Chizzola G; Curello S; Tayeh O; Vizzardi E; Dei Cas L; Ettori F
    EuroIntervention; 2010 Sep; 6(4):461-6. PubMed ID: 20884433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Saphenous vein graft disease.
    Peykar S; Angiolillo DJ; Bass TA; Costa MA
    Minerva Cardioangiol; 2004 Oct; 52(5):379-90. PubMed ID: 15514573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are our patients better off with drug-eluting stents in saphenous vein grafts?
    Douglas JS
    JACC Cardiovasc Interv; 2009 Nov; 2(11):1113-5. PubMed ID: 19926053
    [No Abstract]   [Full Text] [Related]  

  • 18. Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC Trial.
    Vermeersch P; Agostoni P; Verheye S; Van den Heuvel P; Convens C; Bruining N; Van den Branden F; Van Langenhove G
    J Am Coll Cardiol; 2006 Dec; 48(12):2423-31. PubMed ID: 17174178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paclitaxel-eluting vs. bare metal stent implantation in saphenous vein graft lesions: Very long-term follow-up of the SOS (Stenting of Saphenous vein grafts) trial.
    Sosa A; Chao H; Guerra A; Han H; Christopoulos G; Christakopoulos GE; Tarar MN; de Lemos JA; Obel O; Addo T; Roesle M; Haagen D; Rangan BV; Banerjee S; Brilakis ES
    Int J Cardiol; 2015; 186():261-3. PubMed ID: 25828130
    [No Abstract]   [Full Text] [Related]  

  • 20. Frequency and predictors of drug-eluting stent use in saphenous vein bypass graft percutaneous coronary interventions: a report from the American College of Cardiology National Cardiovascular Data CathPCI registry.
    Brilakis ES; Wang TY; Rao SV; Banerjee S; Goldman S; Shunk K; Kar B; Holmes DR; Dai D; Chin CT; Harding TM; Roe MT
    JACC Cardiovasc Interv; 2010 Oct; 3(10):1068-73. PubMed ID: 20965466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.